Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

19

Revenue 2017

Keytruda

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Keytruda was produced by Merck & Co..

FDA panel votes to keep accelerated approval for Roche’s Tecentriq in breast cancer

FDA panel votes to keep accelerated approval for Roche’s Tecentriq in breast cancer Keytruda (pembrolizumab) and Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) in breast, urothelial, gastric and hepatocellular cancers.

GSK discontinues two feladilimab trials in head and neck cancer

GSK discontinues two feladilimab trials in head and neck cancer The mid-stage study is evaluating feladilimab – GSK3359609 – plus Merck &Co’s Keytruda (pembrolizumab) compared with placebo plus Keytruda for the potential treatment of patients with PD-L1 positive advanced or ... In addition, GSK has also halted

Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients

Opdivo plus chemotherapy increases response in pre-surgery NSCLC patients Although Merck &Co’s rival checkpoint inhibitor Keytruda (pembrolizumab) is dominant in the NSCLC setting, it does not possess similar results in the pre-surgery, neoadjuvant setting. ... With the CheckMate-816 results in hand, Opdivo could gain an

Sanofi pays $160m upfront to acquire Tidal Therapeutics

Sanofi pays $160m upfront to acquire Tidal Therapeutics with Merck &Co’s Keytruda (pembrolizumab) in patients with high-risk melanoma and other cancer types.

Keytruda plus chemotherapy gains US approval for advanced oesophageal cancer

Keytruda plus chemotherapy gains US approval for advanced oesophageal cancer Keytruda plus chemotherapy also significantly improved overall survival in this trial, reducing the risk of death by 27%. ... The first-line approval for Keytruda gives it an advantage over rival checkpoint inhibitor Opdivo (nivolumab) from Bristol Myers

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

ASH 2022: bad blood but big advances
Five trends from this year’s ASH conference – and why even pop icons can’t compete with the playlist of innovation shaping haematology...
Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...